Pfizer’s Covid Pill Works Well, Company Confirms in Final Analysisnews2021-12-15T02:22:07+00:00December 15th, 2021|The New York Times|
Pfizer Says Its Covid Pill, Paxlovid, Will Protect Against Severe Diseasenews2021-12-14T12:23:59+00:00December 14th, 2021|The New York Times|
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutationsnews2021-12-04T18:53:12+00:00December 4th, 2021|The New York Times|
In Africa, Dealing With Vaccine Challenges and the Omicron Variantnews2021-12-03T21:55:34+00:00December 3rd, 2021|The New York Times|
In Africa, Dealing With Vaccine Challenges and the Omicron Variantnews2021-12-03T21:55:34+00:00December 3rd, 2021|The New York Times|
Will High Vaccination Rates Help Spain Weather Omicron?news2021-12-02T18:14:26+00:00December 2nd, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
¿Las vacunas funcionan para la variante ómicron?news2021-11-29T23:50:30+00:00November 29th, 2021|The New York Times|
Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.news2021-11-28T23:55:10+00:00November 28th, 2021|The New York Times|